Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05473182 · ClinicalTrials.gov registry record · NA

IndieTrainer: Enabling Individuals With Cerebral Palsy to Receive Power Mobility Training

A NA study, sponsored by Grand Valley State University.

Completed
Registry status
NA
Development phase
25
Enrollment target

NCT05473182: Completed NA study, sponsored by Grand Valley State University.

NCT05473182 is a NA study that has completed, run by Grand Valley State University. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05473182, a NA study, has completed, sponsored by Grand Valley State University.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

Power wheelchairs offer children who are unable to independently opportunities for participation in social, educational, and leisure activities. Unfortunately, children who have severe cognitive, motor, or sensory impairments may need extended training to be able to master the power wheelchairs skills needed to "qualify" for their own power wheelchairs. The IndieTrainer system was developed to address this need. The IndieTrainer system is comprised of the IndieGo device and video-game modules. The IndieGo device temporarily converts a manual wheelchair into a powered wheelchair, thereby allowing children to remain in their own manual wheelchair and use their own custom seating system during power wheelchair skills training activities. The video-game modules are integrated into the IndieGo device such that the video games can be played on a television screen using the specific access method used to control the IndieGo (i.e., switch or joystick). The IndieTrainer system is designed to allow a child to practice power wheelchair skills as part of the video-game modules or as part of more traditional power wheelchair skills training activities wherein children are able to actively explore the environment and practice executing actual wheelchair skills. This study will evaluate the use of the IndieTrainer system in children with cerebral palsy, ages 3-21 years.

Primary Outcome

This outcome will be assessed using each child participant's score (from a minimum of 1 to a maximal of 8) on the Assessment of Learning Powered mobility use. The Assessment of Learning Powered mobility use measures a child's understanding of how to use a power mobility device. Higher scores indicate a better outcome.

Interventions

  • OTHER IndieTrainer system

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2022-09-08
Est. Completion 2023-10-31
Phase NA
Grand Valley State University

11 total trials

What the finished NCT05473182 record still lists

NCT05473182 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which IndieTrainer system is the first listed.

NCT05473182 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05473182 about?

NCT05473182 is a clinical study titled "IndieTrainer: Enabling Individuals With Cerebral Palsy to Receive Power Mobility Training". Power wheelchairs offer children who are unable to independently opportunities for participation in social, educational, and leisure activities. Unfortunately, children who have severe cognitive, motor, or sensory impairments may need extended training to be able to master the power wheelchairs skil...

What is the current status of trial NCT05473182?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2022-09-08. Estimated completion is 2023-10-31.

What interventions are being tested in trial NCT05473182?

The interventions under investigation include: IndieTrainer system (OTHER).

Who is sponsoring clinical trial NCT05473182?

This trial is sponsored by Grand Valley State University, which has 11 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05473182's enrollment target sits among peer trials

25 1712th of 2000 higher than 265 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05473182, the US trial registry maintained by the National Library of Medicine. NCT05473182 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.